Literature DB >> 7561119

Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.

A Menssen1, P Trommler, S Vollmer, D Schendel, E Albert, L Gürtler, G Riethmüller, J C Prinz.   

Abstract

Psoriasis vulgaris is an inflammatory skin disease characterized by excessively increased keratinocyte proliferation. Several lines of evidence support the idea that T cells infiltrating psoriatic skin lesions play a vital role in the pathogenesis of the disease. To establish whether lesional accumulation and activation of T lymphocytes reflect a specific local immune response, the TCR beta-chain variable (V beta) region gene usage was studied in chronic psoriatic plaques, normal skin, and paired blood lymphocytes. By semiquantitative PCR, we found that overexpression of either or both V beta 2 and V beta 6 gene families characterized the TCR repertoires of normal skin and psoriatic skin lesions. However, sequence analysis of the complementarity-determining region 3 (CDR3) of these V beta gene families demonstrated a marked TCR oligoclonality only in psoriatic lesions, not in normal skin or in blood lymphocytes. The amino acid sequences of the lesional TCR clones revealed that certain conserved junctional motifs were shared by different patients. A second biopsy taken from one of the psoriasis patients 18 mo later from a different anatomical site disclosed that the same TCR clones were again dominating. These data suggest that lesional psoriatic T lymphocytes expressing the prevailing TCR V beta genes represent an oligoclonal T cell subset that expanded from a few progenitor T cells in response to Ag in the skin of psoriasis patients. They are derived from a polyclonal T cell population that, by the expression of V beta 2 or V beta 6 TCR, appears to be predisposed for homing to the skin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561119

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Authors:  Barbara S Baker; Jean-Marc Ovigne; Vincent A Fischetti; Anne Powles; Lionel Fry
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammation.

Authors:  S R Lessin; B M Benoit; G Li; A Moskovitz; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

3.  Biased T-cell antigen receptor repertoire in Lyme arthritis.

Authors:  K Roessner; H Trivedi; L Gaur; D Howard; J Aversa; S M Cooper; L H Sigal; R C Budd
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Dermal injection of immunocytes induces psoriasis.

Authors:  T Wrone-Smith; B J Nickoloff
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

5.  Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Authors:  Stanley Cheuk; Maria Wikén; Lennart Blomqvist; Susanne Nylén; Toomas Talme; Mona Ståhle; Liv Eidsmo
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 6.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 7.  [Autoimmune reactions in psoriasis : Spotlight].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

8.  Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

Authors:  Patrick A M Jansen; Diana Rodijk-Olthuis; Edward J Hollox; Marijke Kamsteeg; Geuranne S Tjabringa; Gys J de Jongh; Ivonne M J J van Vlijmen-Willems; Judith G M Bergboer; Michelle M van Rossum; Elke M G J de Jong; Martin den Heijer; Andrea W M Evers; Mieke Bergers; John A L Armour; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

Review 9.  Progress in understanding the immunopathogenesis of psoriasis.

Authors:  R K H Mak; C Hundhausen; F O Nestle
Journal:  Actas Dermosifiliogr       Date:  2009-12

Review 10.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.